• Flora Growth Corp (NASDAQ: FLGC) has signed a definitive agreement to acquire Franchise Global Health Inc (FGH), a multi-national operator in the medical cannabis and pharmaceutical industry. The transaction values Franchise Global Health at about CA$40.0 million.

• The combination of Flora and FGH is expected to deliver at least $3.0 million of annualized cost synergies within the first year following the completion of the acquisition.

• The acquisition would further allow Flora to expand its CBD business in Europe by utilizing FGH's distribution and logistics capabilities.

• FGH's German businesses operate primarily in the export pharmaceutical and medical cannabis import and distribution markets, servicing 1,200 pharmacies in Germany.

• Flora will issue between 36 million and 43 million of its common shares in exchange for the issued and outstanding shares of FGH.

• The company held $10.3 million in cash and equivalents as of June 30, 2022.

• "We plan to work hard to gain market share in the growing German cannabis market as global policy turns the corner," said CEO Clifford Starke.

• Price Action: FLGC shares are trading lower by 1.69% at $0.53 on the last check Monday.

See more from Benzinga

• Mullen Automotive Soars After Securing Sales License For I-GO EV In Europe

• Keurig Dr Pepper Appoints Sudhanshu Priyadarshi As Finance Chief

• If You Invested $100 When Elon Musk First Tweeted About Dogecoin, Here's How Much You'd Have Now - Tesla

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.